SCHEMBL11027481

SCHEMBL11027481

Oc1ccc(Oc2ccc(-c3ccc(Cc4ccccc4)cc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.61
NR1H2 P55055 1/20 0.61
BAX Q07812 1/20 0.61
SRD5A2 P31213 1/20 0.54
ACACB O00763 1/20 0.54
ACACA Q13085 1/20 0.54
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
PTGS1 P23219 1/20 0.53
SLC6A2 P23975 1/20 0.53
CYP2C19 P33261 1/20 0.53
PTGS2 P35354 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HIF1A Q16665 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
ESR1 P03372 2/20 0.52
ESR2 Q92731 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
MMP3 P08254 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8056670 0.88 ESR1 (0.67) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL15940348 0.86 SRD5A2 (0.58) LTA4HSRD5A2ACACBACACAGRIN1
SCHEMBL7039574 0.86 MMP3 (0.68) LMNAPTGS1ESR1ESR2MEN1
SCHEMBL14421265 0.86 ESR1 (0.70) LTA4HNR1H2BAXSRD5A2ESR1
SCHEMBL12804905 0.86 ESR1 (0.70) LTA4HNR1H2BAXSRD5A2ESR1
SCHEMBL5488305 0.86 ESR1 (0.70) LTA4HNR1H2BAXSRD5A2ESR1
SCHEMBL10053900 0.84 SRD5A2 (0.61) LTA4HNR1H2BAXSRD5A2ACACB
SCHEMBL7938048 0.84 MMP3 (0.71) LMNAPTGS1ESR1ESR2MEN1
SCHEMBL5374943 0.84 LTA4H (0.86) LTA4HNR1H2BAXESR1ESR2
SCHEMBL25960632 0.84 LTA4H (0.77) LTA4HNR1H2BAXLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120187392-A1 IMIDAZOPYRIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS CONTAINING SAME IDEMITSU KOSAN CO., LTD (JP) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120187392-A1 IMIDAZOPYRIDINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS CONTAINING SAME TPMT, SLC30A5, IDH2 LTA4H 4469/4885NR1H2 4020/4885BAX 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.